Cargando…

Corrigendum: High‐dose non‐sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825443/
https://www.ncbi.nlm.nih.gov/pubmed/35154642
http://dx.doi.org/10.1002/clt2.12120
_version_ 1784647209909747712
collection PubMed
description
format Online
Article
Text
id pubmed-8825443
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-88254432022-02-11 Corrigendum: High‐dose non‐sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab Clin Transl Allergy Corrigendum John Wiley and Sons Inc. 2022-02-08 /pmc/articles/PMC8825443/ /pubmed/35154642 http://dx.doi.org/10.1002/clt2.12120 Text en © 2022 The Authors. Clinical and Translational Allergy published by John Wiley and Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Corrigendum
Corrigendum: High‐dose non‐sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab
title Corrigendum: High‐dose non‐sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab
title_full Corrigendum: High‐dose non‐sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab
title_fullStr Corrigendum: High‐dose non‐sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab
title_full_unstemmed Corrigendum: High‐dose non‐sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab
title_short Corrigendum: High‐dose non‐sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab
title_sort corrigendum: high‐dose non‐sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825443/
https://www.ncbi.nlm.nih.gov/pubmed/35154642
http://dx.doi.org/10.1002/clt2.12120